PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Clinical and Molecular Hepatology10.3350/cmh.2015.21.1.85201521185Low-dose steroid-induced tumor lysis syndrome in a hepatocellular carcinoma patientJin Ok Kim, Dae Won Jun, Hye Jin Tae, Kang Nyeong Lee, Hang Lak Lee, Oh Young Lee, Ho Soon Choi, Byung Chul Yoon, Joon Soo Hahmhttp://synapse.koreamed.org/pdf/10.3350/cmh.2015.21.1.85, http://synapse.koreamed.org/DOIx.php?id=10.3350/cmh.2015.21.1.85, http://www.e-cmh.org/upload/pdf/cmh-21-85.pdf
Hematology/Oncology and Stem Cell Therapy10.1016/j.hemonc.2018.03.0042020133168-170Sorafenib-induced tumor lysis syndrome in a patient with metastatic hepatocellular carcinomaSardar Zakariya Imam, Mohammad Faizan Zahid, Muhammad Asad Maqboolhttps://api.elsevier.com/content/article/PII:S1658387618300293?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1658387618300293?httpAccept=text/plain
International Journal of Gerontology10.1016/j.ijge.2014.03.005201483171-174Transarterial Chemoembolization-induced Tumor Lysis Syndrome: Different Results in the Same Hepatocellular Carcinoma PatientHsaing-Hung Lin, Wei-Ho Chang, Horng-Yuan Wang, Ming-Jen Chen, Shou-Chuan Shihhttps://api.elsevier.com/content/article/PII:S1873959814000702?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1873959814000702?httpAccept=text/plain
Medical Principles and Practice10.1159/0003603622014236574-576Spontaneous Tumor Lysis Syndrome in a Patient with Metastatic Hepatocellular CarcinomaRaman Mehrzad, Hiroki Saito, Zachary Krahn, Alexander Feinsteinhttps://www.karger.com/Article/Pdf/360362, https://www.karger.com/Article/Pdf/360362, https://www.karger.com/Article/Pdf/360362
European Journal of Radiology Extra10.1016/j.ejrex.2006.02.005200658249-51Acute tumor lysis syndrome after transcatheter arterial chemoembolization in a patient with hepatocellular carcinomaDilip Sharma, Zhenggang Ren, Jinglin Xia, Shenglong Yehttps://api.elsevier.com/content/article/PII:S1571467506000174?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1571467506000174?httpAccept=text/plain
The Oncologist10.1634/theoncologist.11-1-89200611189-89Response to “Acute Tumor Lysis Syndrome After Thalidomide Therapy in Advanced Hepatocellular Carcinoma”Andrew X. Zhuhttps://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.11-1-89, https://onlinelibrary.wiley.com/doi/full-xml/10.1634/theoncologist.11-1-89, https://academic.oup.com/oncolo/article-pdf/11/1/89/41850654/oncolo_11_1_89.pdf, https://academic.oup.com/oncolo/article-pdf/11/1/89/41850654/oncolo_11_1_89.pdf
Clinical Journal of Gastroenterology10.1007/s12328-020-01306-12021142645-649Lenvatinib-induced tumor lysis syndrome in a patient with advanced hepatocellular carcinoma: a case reportYoshiaki Shimizu, Hajime Sunagozaka, Koki Yamagata, Hirokazu Hirai, Miyabi Miura, Yuichiro Yonemoto, Yoshihide Naito, Kenkei Hasatani, Jun Yoshikawa, Hiroyuki Aoyagi, Shuichi Kanekohttp://link.springer.com/content/pdf/10.1007/s12328-020-01306-1.pdf, http://link.springer.com/article/10.1007/s12328-020-01306-1/fulltext.html, http://link.springer.com/content/pdf/10.1007/s12328-020-01306-1.pdf
American Journal of Hematology10.1002/ajh.204442005804309-309Steroid-induced tumor lysis syndrome in a patient with mycosis fungoides treated for presumed pneumocystis carinii pneumoniaPetros Kopterides, Michalis Lignos, Irini Mavrou, Apostolos Armaganidishttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fajh.20444, https://onlinelibrary.wiley.com/doi/full/10.1002/ajh.20444
Cancer Science10.1111/j.1349-7006.2008.00958.x200899102104-2105Acute tumor lysis syndrome after transarterial chemoembolization for hepatocellular carcinomaHiroaki Shiba, Yuichi Ishida, Shigeki Wakiyama, Taro Sakamoto, Takeyuki Misawa, Katsuhiko Yanagahttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1349-7006.2008.00958.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2008.00958.x/fullpdf
American Journal of Kidney Diseases10.1053/j.ajkd.2019.03.2422019735705240 Steroid-Induced Tumor Lysis Syndrome in the Setting of Pembrolizumab Usehttps://api.elsevier.com/content/article/PII:S0272638619304408?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0272638619304408?httpAccept=text/plain